GLOW Blend

GLOW is a research peptide blend combining GHK-Cu, BPC-157, and TB-500. The individual peptides have been studied in preclinical research related to tissue repair, wound healing, cellular signaling, and recovery pathways. The complete blend has not been clinically validated.

Tissue RepairWound HealingRecovery SupportSkin HealthInflammation ResearchCellular Signaling
Vendors
16 vendors
Sizes
70 mg
Intake
Injections

Typical dose

1.4–2.8 mg

No established frequency

Route

Subcutaneous injection

No established timing

Cycle

4–8 weeks.

Typical duration

Storage

2–8°C

Follow vendor guidance

Marketplace

Vendor listings

16 offers for GLOW Blend

VendorPriceRatingShippingCOAAction

Reta One Labs

United StatesFast

$45.00

$0.64/mg

No reviews

2 days

United States

1 file

Renova Peptides

United StatesFast

$49.00

$0.70/mg

No reviews

3–5 days

United States

1 file

Amino Club

United StatesFast

$58.49

$89.99

$0.84/mg

35%
No reviews

1–4 days

United States

1 file

Peptix USA

United StatesFast

$84.96

$90.00

$1.21/mg

5.6%
No reviews

3–5 days

United States

1 file

HLX LABS

United StatesFast

$84.99

$124.99

$1.21/mg

32%
No reviews

2–5 days

United States

1 file

Bionova Peptides

United StatesFast

$89.99

$1.29/mg

No reviews

1–3 days

United States

1 file

LA Peptides

United StatesFast

$89.99

$1.29/mg

No reviews

2–5 days

United States

1 file

prpeps

United StatesFast

$95.00

$1.36/mg

No reviews

2 days

United States

None

What the research reports

Reported research benefits.

GLOW combines GHK-Cu, BPC-157, and TB-500. Research on the individual components suggests potential roles in tissue repair, wound healing, cellular signaling, and recovery. The complete GLOW combination has not been clinically validated.

01

Tissue Repair

02

Wound Healing

03

Skin Health

04

Recovery Support

Dosage and protocol

How it is typically studied.

There is no clinically established dosing protocol for the complete GLOW blend. Published research primarily evaluates the individual components rather than the commercial combination.

01 Route

Subcutaneous injection

02 Example range

No established human range

03 Frequency

No established frequency

04 Timing

No established timing

Educational reference only. Use clinician guidance for dosing decisions.

Evidence

What the studies actually show.

1

GHK-Cu and tissue repair

Experimental studies have investigated GHK-Cu for fibroblast activity, extracellular-matrix production, and tissue-repair processes.

2

BPC-157 and tissue healing

BPC-157 has shown tissue-protective and wound-healing effects in several animal and laboratory models, but robust human clinical evidence is lacking.

3

Thymosin β4 and wound healing

Thymosin β4 has been studied for cell migration, angiogenesis, and wound healing. TB-500 is related to thymosin β4 but should not automatically be considered equivalent to the native peptide.

4

GLOW combination

No controlled clinical study has established the safety, efficacy, dosage, or cycle of the complete GLOW blend.

Interactions

How it pairs with other peptides.

Other peptide blends

No clinical interaction studies have established the safety of combining GLOW with other peptide blends

Anti-inflammatory drugs

Individual GLOW components have demonstrated biological effects related to inflammation, but clinically meaningful interactions with anti-inflammatory drugs have not been established.

Anticoagulants / antiplatelet drugs

No established human drug interaction has been demonstrated for the complete GLOW combination.

Copper supplements

GHK-Cu contains copper. The clinical significance of combining GHK-Cu-containing blends with copper supplementation has not been established.

FAQ

Frequently asked questions.

GLOW is a research peptide blend commonly containing GHK-Cu, BPC-157, and TB-500.